معرفی
Jeffrey Damman is a Researcher in the Department of Pathology at Erasmus University Medical Center Rotterdam, actively contributing to immunology, dermatology, and pharmacology research. His work focuses on kidney transplantation immunology, lichen sclerosus pathogenesis, and translational drug development models, with recent publications spanning clinical pharmacology, AI-enhanced dermatopathology, and molecular genetics of skin disorders.
Dr. Damman's research profile reveals deep expertise in immune responses related to transplantation and autoimmune skin conditions. He investigates graft failure mechanisms in kidney allografts while pioneering studies on juvenile lichen sclerosus outcomes and molecular characterization of SUFU-related skin cancers. His pharmacological work includes developing the KLH challenge model for neo-antigen immune responses and characterizing TLR7 responses for early drug development, demonstrating strong interdisciplinary integration between laboratory science and clinical applications.
Analysis of his 2023-2025 publications shows consistent innovation across three core domains: (1) AI integration in histopathological cancer diagnostics, (2) molecular characterization of genetic mutations in dermatological conditions, and (3) development of immunological challenge models for drug testing. His work frequently bridges immunology with dermatology, particularly in studying immune-mediated skin disorders and transplantation-related immune responses, while maintaining strong methodological focus on clinical trial design and translational biomarker discovery.
No scientific awards were mentioned in the available information.
No details regarding student advising or research grants were provided in the source materials.
No specific laboratory affiliations or research team structures were described in the profile.